Drooid Logo
Back to story perspectives

Full Breakdown

Lurie Children's Hospital Halts Gender-Affirming Medications for Minors Amid Federal Threats

1/22/2026, 1:10:42 AM

Overview of the Situation

Ann & Robert H. Lurie Children’s Hospital in Chicago has announced it will no longer prescribe gender-affirming medications to new patients under the age of 18. This decision follows a referral for investigation by the U.S. Department of Health & Human Services (HHS), announced by General Counsel Mike Stuart on January 15, 2026. The referral includes several other hospitals, such as Nemours Children’s Hospital in Delaware, Boston Children’s Hospital, Children’s Hospital of Philadelphia, New York University Langone Health, and Doernbecher Children’s Hospital in Oregon.

Background & Context

The Trump administration has taken a series of actions against gender-affirming care since taking office, including an executive order in January 2025 that characterized such care as "chemical and surgical mutilation." This order threatened to cut federal grants to providers offering these services to individuals aged 18 and younger. In response to these pressures, Lurie Children’s Hospital had previously ceased performing gender-affirming surgeries for patients younger than 19, leading to protests from patients and advocacy groups.

Official Statements & Responses

Lurie Children’s Hospital stated that the decision to pause new prescriptions for gender-affirming medications was influenced by the HHS's referral for investigation. Hospital spokesperson Julianne Bardele emphasized the impact of federal actions on their ability to provide care, stating, “This threatens our ability to care for all of our patients.” The hospital remains committed to supporting gender-diverse patients, despite the challenges posed by federal scrutiny.

Trans Up Front Illinois, a statewide advocacy group for transgender youth, criticized the announcement, asserting that it has created “fear and uncertainty” for patients and their families. They described the situation as “pre-compliance,” noting that no hospital has lost federal funding, no court has ruled, and no law has changed regarding gender-affirming care.

Criticism & Opposition

The decision by Lurie Children’s Hospital has drawn significant backlash from advocacy groups and legal officials. Illinois Attorney General Kwame Raoul has joined lawsuits against the Trump administration's actions targeting gender-affirming care. Critics argue that the federal government’s threats are designed to intimidate healthcare providers and families before any formal enforcement occurs.

Conflicting Reports & Gaps

While Lurie Children’s Hospital has paused new prescriptions for gender-affirming medications, it remains unclear whether the HHS inspector general's office is actively investigating the hospital. Additionally, the broader implications of the federal government's actions on healthcare systems across Illinois are still unfolding, as other hospitals have also rolled back gender-affirming care for minors.

What's Next

As the legal landscape evolves, Lurie Children’s Hospital is awaiting federal court rulings that may impact its policies on gender-affirming care. Advocacy groups continue to mobilize against the federal government's stance, emphasizing the need for access to comprehensive healthcare for transgender youth.

Verbatim Quotes

  • “Actions by the U.S. Department of Health and Human Services, including their announcement on January 15th of a referral for an investigation of Lurie Children’s, have resulted in this decision.” — Julianne Bardele, Hospital Spokesperson
  • “This announcement has created fear and uncertainty for transgender youth and their families.” — Trans Up Front Illinois
  • “This threatens our ability to care for all of our patients. … We remain committed to our patients and families and their ability to access expert medical care.” — Lurie Children’s Hospital Statement